Psilocybin Research for Substance Use Disorders

[madman]

Recorded Grand Rounds from Johns Hopkins Psychiatry and Behavioral Sciences. Sandeep Nayak, M.D. presented on the topic “Psilocybin for substance use disorders: an overview of current research and future directions at Hopkins” (November 20, 2023). Please note that the window for earning CME credit has expired. #Psychedelics #JohnsHopkins #SUD #Psychiatry https://www.hopkinspsychedelic.org/

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

Opioid-induced hypogonadism - ExcelMale - #1 TRT & Testosterone Forum | Expert-Moderated Men's Health Community

Testosterone deficiency, the unrecognized consequence of the opioid epidemic in men (2022) Janine David, GP and Associate Specialist in Andrology; Mike Kirby, Editor Testosterone deficiency resulting from chronic opioid use can have a profound effect on health and quality of life, but it often...

www.excelmale.com